Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athanasios G Papavassiliou

Showing results (81-90 of 523) with videos related to

Pageof 53
Sort By:
Free Radical Biology & Medicine|September 22, 2018
Redox and NF-κB signaling in osteoarthritisPanagiotis Lepetsos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Metabolism Open|November 11, 2025
Deliberating the striking effect of dual GLP-1R and GIPR agonists on "Diabesity" in light of precision medicine and pharmacogenomicsAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular Physiology|February 22, 2002
Effect of protein kinase inhibitors on the stretch-elicited c-Fos and c-Jun up-regulation in human PDL osteoblast-like cellsDimitris Kletsas, Efthimia K Basdra, Athanasios G Papavassiliou
Cancer Medicine|May 2, 2013
Complexity in cancer biology: is systems biology the answer?Evangelia Koutsogiannouli, Athanasios G Papavassiliou, Nikolaos A Papanikolaou
Nature Chemical Biology|March 19, 2026
Turning KEAP1 against NRF2Christos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
International Journal of Molecular Sciences|June 26, 2025
A Novel Multiplex Diagnostic Algorithm for Developing an Optimal Patient-Tailored Therapy in Rheumatoid Arthritis Based on Molecular StratificationAngeliki Margoni, Alice G Vassiliou, Athanasios G Papavassiliou
Cells|March 29, 2023
Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)Kostas A Papavassiliou, Georgios Marinos, Athanasios G Papavassiliou
Eye (London, England)|November 2, 2025
Transcription factor 4 and Fuchs' endothelial corneal dystrophy (FECD) association: Perspectives for novel targeted therapeuticsAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Molecular Medicine|April 4, 2025
Targeting the Yin and Yang of KRAS<sup>G12C</sup>Christos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Oral Oncology|January 3, 2026
Harnessing TP53 mutational status to enhance prognostic precision and therapeutic effectiveness in head and neck squamous cell carcinomaAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Pageof 53

Showing results (81-90 of 523) with videos related to

Sort By:
Pageof 53
Free Radical Biology & Medicine|September 22, 2018
Redox and NF-κB signaling in osteoarthritisPanagiotis Lepetsos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Metabolism Open|November 11, 2025
Deliberating the striking effect of dual GLP-1R and GIPR agonists on "Diabesity" in light of precision medicine and pharmacogenomicsAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Journal of Cellular Physiology|February 22, 2002
Effect of protein kinase inhibitors on the stretch-elicited c-Fos and c-Jun up-regulation in human PDL osteoblast-like cellsDimitris Kletsas, Efthimia K Basdra, Athanasios G Papavassiliou
Cancer Medicine|May 2, 2013
Complexity in cancer biology: is systems biology the answer?Evangelia Koutsogiannouli, Athanasios G Papavassiliou, Nikolaos A Papanikolaou
Nature Chemical Biology|March 19, 2026
Turning KEAP1 against NRF2Christos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
International Journal of Molecular Sciences|June 26, 2025
A Novel Multiplex Diagnostic Algorithm for Developing an Optimal Patient-Tailored Therapy in Rheumatoid Arthritis Based on Molecular StratificationAngeliki Margoni, Alice G Vassiliou, Athanasios G Papavassiliou
Cells|March 29, 2023
Targeting YAP/TAZ in Combination with PD-L1 Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer (NSCLC)Kostas A Papavassiliou, Georgios Marinos, Athanasios G Papavassiliou
Eye (London, England)|November 2, 2025
Transcription factor 4 and Fuchs' endothelial corneal dystrophy (FECD) association: Perspectives for novel targeted therapeuticsAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Trends in Molecular Medicine|April 4, 2025
Targeting the Yin and Yang of KRAS<sup>G12C</sup>Christos Adamopoulos, Kostas A Papavassiliou, Athanasios G Papavassiliou
Oral Oncology|January 3, 2026
Harnessing TP53 mutational status to enhance prognostic precision and therapeutic effectiveness in head and neck squamous cell carcinomaAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Pageof 53